These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38853795)

  • 1. Neuroleptic malignant syndrome following clozapine withdrawal.
    Tony H; Ashfaq U Rahman AM; Uvais NA
    Ind Psychiatry J; 2024; 33(1):189-190. PubMed ID: 38853795
    [No Abstract]   [Full Text] [Related]  

  • 2. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature.
    Belteczki Z; Ujvari J; Dome P
    Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):148-153. PubMed ID: 34132673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.
    Lee JW; Robertson S
    Ann Clin Psychiatry; 1997 Sep; 9(3):165-9. PubMed ID: 9339882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia.
    Cheng M; Gu H; Zheng L; Wang H; Zhong Z; Wen S
    Neuropsychiatr Dis Treat; 2016; 12():695-7. PubMed ID: 27099499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.
    Meltzer HY; Lee MA; Ranjan R; Mason EA; Cola PA
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):176-87. PubMed ID: 8935814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P; Proppe D; Hoppe-Seyler S
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapine.
    Poyurovsky M; Hermesh H; Weizman A
    Int Clin Psychopharmacol; 1996 Dec; 11(4):283-6. PubMed ID: 9031996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S; Buckley P
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical Neuroleptic Malignant Syndrome: Case Reports and Diagnostic Challenges.
    Szota AM; Radajewska I; Araszkiewicz AS
    J Psychoactive Drugs; 2022; 54(3):284-293. PubMed ID: 34340640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine.
    Leonardo QF; Juliana GR; Fernando CJ
    Case Rep Emerg Med; 2017; 2017():2174379. PubMed ID: 28303200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical neuroleptic malignant syndrome associated with clozapine treatment.
    Amore M; Zazzeri N; Berardi D
    Neuropsychobiology; 1997; 35(4):197-9. PubMed ID: 9246221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E; Ithman M; Lauriello J
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review.
    Yee B; Looi JCL; Agaciak M; Allison S; Chan SKW; Bastiampillai T
    East Asian Arch Psychiatry; 2023 Jun; 33(2):44-64. PubMed ID: 37400227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine withdrawal-emergent dystonias and dyskinesias: a case series.
    Ahmed S; Chengappa KN; Naidu VR; Baker RW; Parepally H; Schooler NR
    J Clin Psychiatry; 1998 Sep; 59(9):472-7. PubMed ID: 9771818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reintroduction of Clozapine following Neuroleptic Malignant Syndrome in a Young Patient with Resistant Schizophrenia.
    Chandad M; Chlihfane R; Kodad S; Oneib B; Elghazouani F
    Case Rep Psychiatry; 2024; 2024():9936663. PubMed ID: 38764874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.